USPTO serial 79299060
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
SG
EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
SG
Other trademarks owned by EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
SG
Other trademarks owned by EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
SG
Other trademarks owned by EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for the treatment of infectious disease and for use in oncology; medical and veterinary preparations, namely, preparations for the treatment of infectious disease and for use in oncology, diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans, pharmaceutical preparations for use in chemotherapy, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for the treatment of viral infections and diseases, and antibacterial pharmaceuticals; pharmaceutical preparations for health care, namely, anti-inflammatory preparations, antipyretic preparations, biological preparations for the treatment of cancer, mixed biological preparations for the treatment and prevention of infectious diseases | ACTIVE | — |
| 010 | Apparatus for medical use, namely, insulin pumps, insulin injectors sold empty, medical fluid injectors | ACTIVE | — |
| 042 | Research and development services relating to medicines; medical laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of medical apparatus for others; biotechnology research; research relating to pharmaceuticals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 24, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 24, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 11, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 11, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 26, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 26, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 18, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 18, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 18, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 19, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 22, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 22, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 21, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 20, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 5, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |